Evaluation of Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2015.1008877
Full Text
Open PDFAbstract
Available in full text
Date
April 27, 2015
Authors
Publisher
Informa UK Limited